Hypothesis: the potential utility of topical eflornithine against cutaneous leishmaniasis.
Namazi
M R
MR
D000287:Administration, Topical; D000518:Eflornithine / Q000008:administration & dosage*; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000473:pathology
D000518:Eflornithine